{"id":"14c-azd4635-iv-microtracer-fasted","_chembl":null,"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T04:30:46.786Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123052,"model":"claude-sonnet-4-5-20250929"},"description":"[14C] AZD4635 IV microtracer - fasted is a radiolabeled investigational compound developed by AstraZeneca for Phase 1 clinical studies. This formulation is used in pharmacokinetic and metabolism studies to track drug distribution and elimination in the body under fasting conditions.","indications":{"approved":[{"status":"investigational","condition":"Pharmacokinetic study in healthy volunteers","patientPopulation":"Adult healthy volunteers"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"[14C] AZD4635 IV microtracer - fasted","genericName":"[14C] AZD4635 IV microtracer - fasted","companyName":"AstraZeneca","companyId":"astrazeneca","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}